Abstract

The goal of the Harvard M.D.-Ph.D. Program (Medical Scientist Training Program) is to train clinician-scientists who will be at the forefront of biomedical research and provide an interface between the most basic biomedical and technical research and its clinical application at the bedside. It is expected that these individuals will comprise a significant proportion of the future medical school faculties and will be able to address problems of disease etiology, pathophysiology and treatment at the most fundamental levels. These general goals are being pursued by selecting for our program the most research oriented and academically promising undergraduates and medical students who demonstrate a serious and long term commitment to academic careers in biomedical research. The M.D.-Ph.D. Program seeks to provide these students with the most thorough and up-to-date medical education and training for research careers in the laboratories and some of best investigators at Harvard and the Massachusetts Institute of Technology.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007753-23
Application #
6350995
Study Section
National Institute of General Medical Sciences Initial Review Group (BRT)
Program Officer
Shapiro, Bert I
Project Start
1979-07-01
Project End
2002-06-30
Budget Start
2001-07-01
Budget End
2002-06-30
Support Year
23
Fiscal Year
2001
Total Cost
$1,718,562
Indirect Cost

  Institution

Name
Harvard University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
082359691
City
Boston
State
MA
Country
United States
Zip Code
02115

  Publications

Rodin, Rachel E; Walsh, Christopher A (2018) Somatic Mutation in Pediatric Neurological Diseases. Pediatr Neurol 87:20-22
Sievers, Quinlan L; Petzold, Georg; Bunker, Richard D et al. (2018) Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362:
Rodan, Lance H; Hauptman, Marissa; D'Gama, Alissa M et al. (2018) Novel founder intronic variant in SLC39A14 in two families causing Manganism and potential treatment strategies. Mol Genet Metab 124:161-167
Gusev, Alexander; Mancuso, Nicholas; Won, Hyejung et al. (2018) Transcriptome-wide association study of schizophrenia and chromatin activity yields mechanistic disease insights. Nat Genet 50:538-548
Lodato, Michael A; Rodin, Rachel E; Bohrson, Craig L et al. (2018) Aging and neurodegeneration are associated with increased mutations in single human neurons. Science 359:555-559
Short, Francesca L; Akusobi, Chidiebere; Broadhurst, William R et al. (2018) The bacterial Type III toxin-antitoxin system, ToxIN, is a dynamic protein-RNA complex with stability-dependent antiviral abortive infection activity. Sci Rep 8:1013
Miyamoto, David T; Lee, Richard J; Kalinich, Mark et al. (2018) An RNA-Based Digital Circulating Tumor Cell Signature Is Predictive of Drug Response and Early Dissemination in Prostate Cancer. Cancer Discov 8:288-303
Kalinich, Mark; Haber, Daniel A (2018) Cancer detection: Seeking signals in blood. Science 359:866-867
Wutz, Andreas; Loonis, Roman; Roy, Jefferson E et al. (2018) Different Levels of Category Abstraction by Different Dynamics in Different Prefrontal Areas. Neuron 97:716-726.e8
Fan, Xin; Xie, Bobo; Zou, Jun et al. (2018) Novel ETFDH mutations in four cases of riboflavin responsive multiple acyl-CoA dehydrogenase deficiency. Mol Genet Metab Rep 16:15-19

Showing the most recent 10 out of 867 publications